Inhibitory anti ADAMTS13 antibodies with a new rapid fully automated CLiA assay
Barbara Montaruli(A. O. Ordine Mauriziano di Torino), Domenico Cosseddu(A. O. Ordine Mauriziano di Torino), Laura Solfietti(Azienda Ospedaliero Universitaria San Giovanni Battista), Bruno Brando(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Ivo Beverina(Azienda Ospedaliera Ospedale Civile di Legnano), Chiara Novelli(Azienda Ospedaliera Ospedale Civile di Legnano), Dario Roccatello(5T Torino (Italy)), Mario Bazzan(Ospedale San Giovanni Bosco), Alessandra Valpreda(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino)
Cited by 5
Related Papers
Three Months versus One Year of Oral Anticoagulant Therapy for Idiopathic Deep Venous Thrombosis
|New England Journal of Medicine|2001|599
Enoxaparin for the Prevention of Venous Thromboembolism Associated With Central Vein Catheter: A Double-Blind, Placebo-Controlled, Randomized Study in Cancer Patients
|Journal of Clinical Oncology|2005|305
Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study
|Arthritis & Rheumatology|2021|165
Risk factors for upper limb deep vein thrombosis associated with the use of central vein catheter in cancer patients
|Internal and Emergency Medicine|2008|126
HYdroxychloroquine to Improve Pregnancy Outcome in Women with AnTIphospholipid Antibodies (HYPATIA) Protocol: A Multinational Randomized Controlled Trial of Hydroxychloroquine versus Placebo in Addition to Standard Treatment in Pregnant Women with Antiphospholipid Syndrome or Antibodies
|Seminars in Thrombosis and Hemostasis|2017|125